Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26397949.
- Also identified by DOI 10.1056/NEJMoa1504869 and PMC identifier 4612399.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent discoveries of somatic mutations permit the recognition of subtypes of aldosterone-producing adenomas with distinct clinical presentations and pathological features. Here we describe three women with hyperaldosteronism, two who presented in pregnancy and one who presented after menopause. Their aldosterone-producing adenomas harbored activating mutations of CTNNB1, encoding β-catenin in the Wnt cell-differentiation pathway, and expressed LHCGR and GNRHR, encoding gonadal receptors, at levels that were more than 100 times as high as the levels in other aldosterone-producing adenomas. The mutations stimulate Wnt activation and cause adrenocortical cells to de-differentiate toward their common adrenal-gonadal precursor cell type. (Funded by grants from the National Institute for Health Research Cambridge Biomedical Research Centre and others.).
Medical subject headings
- Adenoma
- Adrenal Gland Neoplasms
- Hyperaldosteronism
- Pregnancy Complications, Neoplastic
- beta Catenin